https://stock.noler.com/us/stock/titan-pharmaceuticals-inc https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accounts-and-notes-receivable-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accounts-payable-interest-bearing-interest-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accounts-receivable-gross https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/accumulated-depreciation-depletion-and-amortization-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/amortization-of-deferred-loan-origination-fees-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cash https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/common-stock-no-par-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/contract-liability https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/contract-with-customer-asset-gross https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/convertible-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-and-capital-lease-obligations https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-annual-principal-payment https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-face-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-periodic-payment-interest https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-periodic-payment-principal https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-unamortized-discount-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/debt-unamortized-discount-noncurrent https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-income-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-revenue-additions https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-sales-inducements-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/fair-value-option-changes-in-fair-value-gain-loss https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/financial-instruments-owned-corporate-equities-at-fair-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/gain-loss-on-contract-termination https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/gain-on-sale-of-investments https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/gain-or-loss-on-sale-of-stock-in-subsidiary https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/gains-losses-on-sales-of-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-contract-receivables-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-notes-receivables https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/increase-decrease-in-royalties-payable https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/insurance-commissions https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/inventory-raw-materials-and-supplies-net-of-reserves https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/labor-and-related-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/legal-fees https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/level-3-liability-issues https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/level-3-liability-transfers-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/line-of-credit-facility-collateral-fees-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/noncash-contribution-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/noninterest-expense-directors-fees https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/oci-tax https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/other-asset-impairment-charges https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/other-noncash-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/ownshare-lending-arrangement-collateral https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/patents-active https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/patents-pending https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/patents-rejected https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/payments-for-royalties https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/pending-claims-number https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-sale-of-other-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-sale-of-other-investments https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-subordinated-short-term-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/product-warranty-accrual-classified-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/professional-fees https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/receivables-net-current https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/reclassifications-of-temporary-to-permanent-equity https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/repayments-of-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/repayments-of-subordinated-short-term-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/restricted-cash https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/revenue-from-grants https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/royalty-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/royalty-revenue https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-10-12g https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-10ksb40 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-10qsb https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-15-12b https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-25 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-certnas https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-defn14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-defr14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-dfan14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-pren14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-prrn14a https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-aw https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/severance-costs https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-based-goods-and-nonemployee-services-transaction-valuation-method-expected-dividend-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-based-goods-and-nonemployee-services-transaction-valuation-method-risk-free-interest-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/shares-issued-shares-issued-for-noncash-consideration https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/shares-subject-to-mandatory-redemption-settlement-terms-number-of-shares https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/short-term-debt-refinanced-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-payments https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-options-other-share-increase-decrease-in-period-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-option-plan-expense https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/titan-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted